¥1,714.00
1.04% today
Tokyo, Oct 20, 08:15 am CET
ISIN
JP3495000006
Symbol
4506
Index

Sumitomo Dainippon Pharma Stock price

¥1,710.00
+38.00 2.27% 1M
+1,083.00 172.73% 6M
+1,147.00 203.73% YTD
+1,087.00 174.48% 1Y
+669.00 64.27% 3Y
+492.00 40.39% 5Y
+389.09 29.46% 10Y
+496.27 40.89% 20Y
Tokyo, Closing price Mon, Oct 20 2025
-22.00 1.27%
ISIN
JP3495000006
Symbol
4506
Index
Industry

Key metrics

Basic
Market capitalization
¥710.4b
Enterprise Value
¥983.3b
Net debt
¥272.9b
Cash
¥36.3b
Shares outstanding
397.3m
Valuation (TTM | estimate)
P/E
36.4 | 10.5
P/S
1.7 | 1.7
EV/Sales
2.4 | 2.3
EV/FCF
62.3
P/B
4.0
Dividends
DPS
¥0.00
Yield 1Y | 5Y
0.0% | 1.4%
Growth 1Y | 5Y
- | -100.0%
Payout 1Y | 3Y
0.0% | -2.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥416.2b | ¥421.8b
EBITDA
¥77.7b | ¥109.5b
EBIT
¥53.9b | ¥27.3b
Net Income
¥18.9b | ¥65.5b
Free Cash Flow
¥15.8b
Growth (TTM | estimate)
Revenue
26.3% | 5.8%
EBITDA
128.7% | 183.0%
EBIT
117.6% | 47.5%
Net Income
107.3% | 177.1%
Free Cash Flow
110.4%
Margin (TTM | estimate)
Gross
60.9%
EBITDA
18.7% | 26.0%
EBIT
12.9%
Net
4.5% | 15.5%
Free Cash Flow
3.8%
Financial Health
Equity Ratio
22.8%
Return on Equity
14.0%
ROCE
10.7%
ROIC
16.0%
Debt/Equity
1.8
More
EPS
¥47.6
FCF per Share
¥39.7
Short interest
-
Employees
5k
Rev per Employee
¥80.1m
Show more

Is Sumitomo Dainippon Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Sumitomo Dainippon Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Sumitomo Dainippon Pharma forecast:

6x Buy
55%
3x Hold
27%
2x Sell
18%

Analyst Opinions

11 Analysts have issued a Sumitomo Dainippon Pharma forecast:

Buy
55%
Hold
27%
Sell
18%

Financial data from Sumitomo Dainippon Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
416,159 416,159
26% 26%
100%
- Direct Costs 162,600 162,600
24% 24%
39%
253,559 253,559
28% 28%
61%
- Selling and Administrative Expenses 170,476 170,476
57% 57%
41%
- Research and Development Expense 44,916 44,916
54% 54%
11%
77,710 77,710
129% 129%
19%
- Depreciation and Amortization 23,858 23,858
33% 33%
6%
EBIT (Operating Income) EBIT 53,852 53,852
118% 118%
13%
Net Profit 18,903 18,903
107% 107%
5%

In millions JPY.

Don't miss a Thing! We will send you all news about Sumitomo Dainippon Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sumitomo Dainippon Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

Head office Japan
CEO Toru Kimura
Employees 4,980
Founded 1897
Website www.sumitomo-pharma.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today